Summary
Library

Large bruise on the abdomen of a patient on warfarin with acquired factor V inhibitor

Bruising affecting the thigh and pelvic area in a patient with vitamin C deficiency

Diagnostic algorithm for the workup of easy bruising (*Test usually not ordered in the US)

Bruising in patient with vasculitis (drug-induced)
Citations
Faughnan ME, Mager JJ, Hetts SW, et al. Second international guidelines for the diagnosis and management of hereditary hemorrhagic telangiectasia. Ann Intern Med. 2020 Dec 15;173(12):989-1001.[Abstract][Full Text]
Tiede A, Collins P, Knoebl P, et al. International recommendations on the diagnosis and treatment of acquired hemophilia A. Haematologica. 2020 Jul;105(7):1791-801.[Abstract][Full Text]
Neunert C, Terrell DR, Arnold DM, et al. American Society of Hematology 2019 guidelines for immune thrombocytopenia. Blood Adv. 2019 Dec 10;3(23):3829-66.[Abstract][Full Text]
Rodeghiero F, Tosetto A, Abshire T, et al. ISTH/SSC bleeding assessment tool: a standardized questionnaire and a proposal for a new bleeding score for inherited bleeding disorders. J Thromb Haemost. 2010;8:2063-2065.[Full Text]
1. Mauer AC, Khazanov NA, Levenkova N, et al. Impact of sex, age, race, ethnicity and aspirin use on bleeding symptoms in healthy adults. J Thromb Haemost. 2011;9:100-108.[Abstract][Full Text]
2. Faughnan ME, Mager JJ, Hetts SW, et al. Second international guidelines for the diagnosis and management of hereditary hemorrhagic telangiectasia. Ann Intern Med. 2020 Dec 15;173(12):989-1001.[Abstract][Full Text]
3. Reincke M, Fleseriu M. Cushing syndrome: a review. JAMA. 2023 Jul 11;330(2):170-81.[Abstract]
4. Li Y, Dong S, Wang P, et al. Influence of low-molecular-weight heparin injection sites on local bruising and pain: a systematic review and meta-analysis. J Clin Pharm Ther. 2021 Jun;46(3):688-97.[Abstract]
5. Kimble LP, Momary KM, Adewuyi M. A qualitative study of nuisance bleeding and medication-related beliefs with dual antiplatelet drug therapy. Heart Lung. 2018 Sep-Oct;47(5):485-8.[Abstract]
6. Johnson S, Katyal N, Narula N, et al. Adverse side effects associated with corticosteroid therapy: a study in 39 patients with generalized myasthenia gravis. Med Sci Monit. 2021 Oct 28;27:e933296.[Abstract][Full Text]
7. Guillot B. Adverse skin reactions to inhaled corticosteroids. Expert Opin Drug Saf. 2002 Nov;1(4):325-9.[Abstract]
8. Krasowska D, Szymanek M, Schwartz RA, et al. Cutaneous effects of the most commonly used antidepressant medication, the selective serotonin reuptake inhibitors. J Am Acad Dermatol. 2007 May;56(5):848-53.[Abstract]
9. Pai VB, Kelly MW. Bruising associated with the use of fluoxetine. Ann Pharmacother. 1996 Jul-Aug;30(7-8):786-8.[Abstract]
10. Bolton-Maggs PH, Chalmers EA, Collins PW, et al. A review of inherited platelet disorders with guidelines for their management on behalf of the UKHCDO. Br J Haematol. 2006;135:603-633.[Abstract][Full Text]
11. Balduini CL, Cattaneo M, Fabris F, et al. Inherited thrombocytopenias: a proposed diagnostic algorithm from the Italian Gruppo di Studio delle Piastrine. Haematologica. 2003;88:582-592.[Abstract]
12. Dawood BB, Lowe GC, Lordkipanidzé M, et al. Evaluation of participants with suspected heritable platelet function disorders including recommendation and validation of a streamlined agonist panel. Blood. 2012;120:5041-5049.[Abstract][Full Text]
13. Connell NT, Flood VH, Brignardello-Petersen R, et al. ASH ISTH NHF WFH 2021 guidelines on the management of von Willebrand disease. Blood Adv. 2021 Jan 12;5(1):301-25.[Abstract][Full Text]
14. Mumford AD, Ackroyd S, Alikhan R, et al. Guideline for the diagnosis and management of the rare coagulation disorders: a United Kingdom Haemophilia Centre Doctors' Organization guideline on behalf of the British Committee for Standards in Haematology. Br J Haematol. 2014;167:304-326.[Abstract][Full Text]
15. Franchini M, Mannucci PM. Acquired haemophilia A: a 2013 update. Thromb Haemost. 2013; 110(06): 1114-20.[Abstract]
16. Collins P, Chalmers E, Hart D, et al. Diagnosis and management of acquired coagulation inhibitors: a guideline from UKHCDO. Br J Haematol. 2013;162:758-773.[Abstract][Full Text]
17. Ivanov OL, Lvov AN, Michenko AV, et al. Autoerythrocyte sensitization syndrome (Gardner-Diamond syndrome): review of the literature. J Eur Acad Dermatol Venereol. 2009;23:499-504.[Abstract]
18. Mahmoud AA, Mostafa M, Abdelhay A, et al. Characterization of bleeding in thrombotic thrombocytopenic purpura in the precaplacizumab era: a retrospective nationwide analysis. Res Pract Thromb Haemost. 2025 Jan;9(1):102654.[Abstract][Full Text]
19. Scully M, Rayment R, Clark A, et al. A British Society for Haematology Guideline: diagnosis and management of thrombotic thrombocytopenic purpura and thrombotic microangiopathies. Br J Haematol. 2023 Nov;203(4):546-63.[Abstract][Full Text]
20. Leisring J, Brodsky SV, Parikh SV. Clinical evaluation and management of thrombotic microangiopathy. Arthritis Rheumatol. 2024 Feb;76(2):153-65.[Abstract][Full Text]
21. Kempton CL, White GC 2nd. How we treat a hemophilia A patient with a factor VIII inhibitor. Blood. 2009;113:11-17.[Abstract][Full Text]
22. Tiede A, Rand JH, Budde U, et al. How I treat the acquired von Willebrand syndrome. Blood. 2011;117:6777-6785.[Abstract][Full Text]
23. Tiede A, Collins P, Knoebl P, et al. International recommendations on the diagnosis and treatment of acquired hemophilia A. Haematologica. 2020 Jul;105(7):1791-801.[Abstract][Full Text]
24. Jeon K, Kim M, Lee J, et al. Immature platelet fraction: a useful marker for identifying the cause of thrombocytopenia and predicting platelet recovery. Medicine (Baltimore). 2020 Feb;99(7):e19096.[Abstract][Full Text]
25. Lakshmanan S, Cuker A. Contemporary management of primary immune thrombocytopenia in adults. J Thromb Haemost. 2012;10:1988-1998.[Abstract][Full Text]
26. George JN. Sequence of treatments for adults with primary immune thrombocytopenia. Am J Hematol. 2012;87(suppl 1):S12-S15.[Abstract][Full Text]
27. Neunert C, Terrell DR, Arnold DM, et al. American Society of Hematology 2019 guidelines for immune thrombocytopenia. Blood Adv. 2019 Dec 10;3(23):3829-66.[Abstract][Full Text]
28. Rodeghiero F, Tosetto A, Abshire T, et al. ISTH/SSC bleeding assessment tool: a standardized questionnaire and a proposal for a new bleeding score for inherited bleeding disorders. J Thromb Haemost. 2010;8:2063-2065.[Full Text]
29. Elbatarny M, Mollah S, Grabell J, et al. Normal range of bleeding scores for the ISTH-BAT: adult and pediatric data from the merging project. Haemophilia. 2014;20:831-835.[Abstract][Full Text]
30. Suniega EA, Krenek L, Stewart G. Child abuse: approach and management. Am Fam Physician. 2022 May 1;105(5):521-8.[Abstract][Full Text]
31. Acosta M, Edwards R, Jaffee IM, et al. A practical approach to pediatric patients referred with an abnormal coagulation profile. Arch Pathol Lab Med. 2005 Aug;129(8):1011-6.[Abstract][Full Text]
32. Drivenes JL, Bygum A. Spontaneous oral purpura in immune thrombocytopenia. N Engl J Med. 2024 Mar 14;390(11):1029.
33. Beighton P, Horan F. Orthopaedic aspects of the Ehlers-Danlos syndrome. J Bone Joint Surg Br. 1969;51:444-453.[Abstract][Full Text]
34. Fleseriu M, Auchus R, Bancos I, et al. Consensus on diagnosis and management of Cushing's disease: a guideline update. Lancet Diabetes Endocrinol. 2021 Dec;9(12):847-75.[Abstract][Full Text]
35. Nutescu EA, Burnett A, Fanikos J, et al. Pharmacology of anticoagulants used in the treatment of venous thromboembolism. J Thromb Thrombolysis. 2016 Jan;41(1):15-31.[Abstract][Full Text]
36. Breen KA, Grimwade D, Hunt BJ. The pathogenesis and management of the coagulopathy of acute promyelocytic leukaemia. Br J Haematol. 2012;156(1):24-36.[Abstract][Full Text]